Many Americans, including patients with cancer, use cannabis and cannabinoids. In response to this reality, the American Society of Clinical Oncology (ASCO) has issued a guideline for clinicians, adults with cancer, caregivers, and researchers on their medical use. The recommendations cover all cancer types and address products ranging from synthetic cannabinoids to full-spectrum cannabis.